Prof. Dave Singh
, Stanford University, USATitle : 3D upper airway changes in Korean adults following biomimetic oral appliance therapy
Abstract
It is known that a small
upper airway or one that is highly collapsible is an important factor in
increasing the risk of obstructive sleep. Therefore, in this study we investigated 3D
changes of the nasopharyngeal and
oropharyngeal airway apnea in adults, to test the hypothesis that the combined
upper airway can be non-surgically improved in adults using Biomimetic Oral Appliance Therapy (BOAT). BOAT differs
from mandibular advancement devices since it aims to correct the nasal
cavity and oropharyngeal regions of the upper
airway. After obtaining appropriate consent, 3D Cone-Beam Computerized
Tomographic (CBCT) scans of 13 Korean adults diagnosed with midfacial
hypoplasia were taken prior to BOAT. Post-treatment, follow-up 3D CBCT scans were
undertaken with no device in the patient’s mouth. After 3D craniofacial reconstruction was
undertaken, pre- and post-treatment nasopharyngeal
and oropharyngeal airway volumes (from the
nasal cavity to the level of the hyoid bone) were calculated, and the
findings were subjected to univariate statistical tests. The mean age of the sample was 29.6yrs ±
9.0. The mean treatment time with BOAT
was 16.3 ± 5.2 months. The mean
pre-treatment upper airway volume was found to be 43.3cm3 ±
6.5. Post-treatment, the mean upper
airway volume increased by 12% to 48.5cm3 ± 9.6 with no device in
the patient’s mouth, which was statistically significant (p < 0.01). These findings suggest that the morphology of
the upper airway can be non-surgically improved in non-growing adults. These induced upper airway enhancements may
correspond to functional airway behavior and might provide an alternative
therapy for obstructive sleep apnea in adults.
Further studies are now required to correlate these structural upper
airway improvements to polysomnographic parameters during sleep.
Biography
Prof. Dave Singh is a US citizen
who holds three doctorates. He is the founder and chief medical officer of
Vivos Therapeutics, Inc., USA and adjunct professor, sleep medicine, Stanford
University, USA. He has over 200 publications in the medical, dental and
orthodontic literature and has published several books/book chapters. He has
been serving as a board member of the American Sleep and Breathing Academy and
is a member of the World Sleep Society.